Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma.

J Cell Mol Med · 2009 · PMC4516549 · PMID 20196789

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The proportion of actively migrating lymphocytes was slightly decreased after exposure to EpCAMxCD3 compared with controls; however, the difference did not reach statistical significance (Fig. 3C ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.